Search Results - "Barcenilla, B."

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis by Jiménez-Jiménez, F. J., Hernánz, A., Medina-Acebrón, S., De Bustos, F., Zurdo, J. M., Alonso, H., Puertas, I., Barcenilla, B., Sayed, Y., Cabrera-Valdivia, F.

    Published in Acta neurologica Scandinavica (01-02-2005)
    “…Objective – To elucidate whether cerebrospinal fluid (CSF) concentrations of the microtubule‐associated tau protein are related to the risk for sporadic…”
    Get full text
    Journal Article
  2. 2

    Tau protein concentrations in cerebrospinal fluid of patients with multiple sclerosis by Jiménez-Jiménez, F. J., Zurdo, J. M., Hernanz, A., Medina-Acebrón, S., De Bustos, F., Barcenilla, B., Sayed, Y., Ayuso-Peralta, L.

    Published in Acta neurologica Scandinavica (01-12-2002)
    “…Fundamentals and objective – Multiple sclerosis (MS) is the prototype of demyelinating disease, but recently, it has been shown that the existence of axonal…”
    Get full text
    Journal Article
  3. 3

    Serum levels of coenzyme Q10 in patients with Parkinson's disease by JIMENEZ-JIMENEZ, F. J, MOLINA, J. A, ENRIQUEZ DE SALAMANCA, R, ARENAS, J, DE BUSTOS, F, GARCIA-REDONDO, A, GOMEZ-ESCALONILLA, C, MARTINEZ-SALIO, A, BERBEL, A, CAMACHO, A, ZURDO, M, BARCENILLA, B

    Published in Journal of Neural Transmission (2000)
    “…We compared serum levels of coenzyme Q10 and the coenzyme Q10/cholesterol ratio in 33 patients with Parkinson's disease (PD) and 31 matched controls. The mean…”
    Get full text
    Journal Article
  4. 4

    Serum levels of coenzyme Q10 in patients with Alzheimer's disease by DE BUSTOS, F, MOLINA, J. A, ENRIQUEZ-DE-SALAMANCA, R, ARENAS, J, JIMENEZ-JIMENEZ, F. J, GARCIA-REDONDO, A, GOMEZ-ESCALONILLA, C, PORTA-ETESSAM, J, BERBEL, A, ZURDO, M, BARCENILLA, B, PARRILLA, G

    Published in Journal of Neural Transmission (2000)
    “…We compared serum levels of coenzyme Q10 and the coenzyme Q10/cholesterol ratio in 44 patients with Alzheimer's disease (AD), 17 patients with vascular…”
    Get full text
    Journal Article
  5. 5

    Normal cerebrospinal fluid levels of insulin in patients with Parkinson's disease by JIMENEZ-JIMENEZ, F. J, MOLINA, J. A, ARENAS, J, VARGAS, C, GOMEZ, P, DE BUSTOS, F, ZURDO, M, GOMEZ-ESCALONILLA, C, BARCENILLA, B, BERBEL, A, CAMACHO, A

    Published in Journal of Neural Transmission (01-01-2000)
    “…We compared CSF levels insulin, measured by a Radioimmunoanalysis method, in 24 patients with Parkinson's disease (PD) and 21 matched controls. The CSF insulin…”
    Get full text
    Journal Article
  6. 6

    Possible zoophilia associated with dopaminergic therapy in Parkinson disease by JIMENEZ-JIMENEZ, Felix Javier, SAYED, Youssef, GARCIA-SOLDEVILLA, Miguel Angel, BARCENILLA, Beatriz

    Published in The Annals of pharmacotherapy (01-07-2002)
    “…To report a patient with Parkinson disease (PD) who developed zoophilia as a possible complication of dopaminergic therapy. A 74-year-old man with advanced PD,…”
    Get full text
    Journal Article
  7. 7

    Cerebrospinal fluid levels of thiamine in patients with Parkinson's disease by Jiménez-Jiménez, Félix Javier, Molina, José Antonio, Hernánz, Angel, Fernández-Vivancos, Estrella, de Bustos, Fernando, Barcenilla, Beatriz, Gómez-Escalonilla, Carlos, Zurdo, Martı́n, Berbel, Angel, Villanueva, Clara

    Published in Neuroscience letters (13-08-1999)
    “…Thiamine is an essential cofactor for several important enzymes involved in brain oxidative metabolism, such as the alpha-ketoglutarate dehydrogenase complex…”
    Get full text
    Journal Article
  8. 8

    Possible zoophilia associated with dopaminergic therapy in Parkinson disease by Jimenez-Jimenez, FJ, Sayed, Y, Garcia-Soldevilla, MA, Barcenilla, B

    Published in The Annals of pharmacotherapy (01-07-2002)
    “…OBJECTIVE: To report a patient with Parkinson disease (PD) who developed zoophilia as a possible complication of dopaminergic therapy. CASE SUMMARY: A…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Olanzapine improves chorea in patients with Huntington's disease by Jiménez-Jiménez, F J, de Toledo, M, Puertas, I, Barón, M, Zurdo, M, Barcenilla, B

    Published in Revista de neurologiá (16-09-2002)
    “…The main treatment for choreatic movements associated to Huntington s disease are the neuroleptic drugs, however, its use causes long term troubles. We…”
    Get full text
    Journal Article
  11. 11

    Respiratory insufficiency as the first sign of mitochondrial disorders by Ortí-Pareja, M, Jiménez-Jiménez, F J, Barcenilla, B, Montero, E, Marcos, J, García-Albea, E

    Published in Revista de neurologiá (16-10-1999)
    “…In spite of the great variability in clinical signs in the mitochondrial disorders, reports of respiratory disorders in these conditions are purely anecdotal,…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Respiratory form of onset of motor neuron disease by Tallón-Barranco, A, Ayuso-Peralta, L, Jiménez-Jiménez, F J, Flores, J, Vázquez-Mezquita, M, Barcenilla, B, Zurdo, M

    Published in Revista de neurologiá (01-01-2000)
    “…To present a case of respiratory failure as the form of onset of amyotrophic lateral sclerosis, to review the main clinical findings, data of the…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    The value of C-reactive protein in the diagnosis of acute pneumopathies in children by Matesanz, J L, Málaga, S, Barcenilla, B G, Zazua, J, Crespo, M

    Published in Anales españoles de pediatría (01-06-1983)
    “…We have studied 164 children with pneumopathy, ranging from one month to 8 years old. They were classified in two groups according as clinical, biological and…”
    Get more information
    Journal Article